Target
Phospholipase A2
Ligand
BDBM80846
Substrate
n/a
Meas. Tech.
Dose response counterscreen of uHTS hits for ATG4B inhibitors in a Phospholipase A2 assay
IC50
2050±n/a nM
Citation
 PubChem, PC Dose response counterscreen of uHTS hits for ATG4B inhibitors in a Phospholipase A2 assay PubChem Bioassay (2011)[AID] 
Target
Name:
Phospholipase A2
Synonyms:
Group IB phospholipase A2 | PA21B_HUMAN | PLA2 | PLA2A | PLA2G1B | PPLA2 | Phosphatidylcholine 2-acylhydrolase 1B | Phospholipase A2 (PLA2) | Phospholipase A2 group 1B | phospholipase A2 precursor
Type:
Protein
Mol. Mass.:
16364.13
Organism:
Homo sapiens (Human)
Description:
P04054
Residue:
148
Sequence:
MKLLVLAVLLTVAAADSGISPRAVWQFRKMIKCVIPGSDPFLEYNNYGCYCGLGGSGTPVDELDKCCQTHDNCYDQAKKLDSCKFLLDNPYTHTYSYSCSGSAITCSSKNKECEAFICNCDRNAAICFSKAPYNKAHKNLDTKKYCQS
  
Inhibitor
Name:
BDBM80846
Synonyms:
2-[[3-(cyclohexylmethyl)-4-keto-quinazolin-2-yl]thio]propionic acid ethyl ester | 2-[[3-(cyclohexylmethyl)-4-oxo-2-quinazolinyl]thio]propanoic acid ethyl ester | MLS000537883 | SMR000144125 | cid_2959700 | ethyl 2-[3-(cyclohexylmethyl)-4-oxidanylidene-quinazolin-2-yl]sulfanylpropanoate | ethyl 2-[3-(cyclohexylmethyl)-4-oxoquinazolin-2-yl]sulfanylpropanoate | ethyl 2-{[3-(cyclohexylmethyl)-4-oxo-3,4-dihydro-2-quinazolinyl]thio}propanoate
Type:
Small organic molecule
Emp. Form.:
C20H26N2O3S
Mol. Mass.:
374.497
SMILES:
CCOC(=O)C(C)Sc1nc2ccccc2c(=O)n1CC1CCCCC1
Structure:
Search PDB for entries with ligand similarity: